Dr. Sandeep Reddy appointed as CMO of NantHealth

NantHealth announced that Dr. Sandeep Reddy has been appointed as Chief Medical Officer. He will be responsible for overseeing education, outreach, clinical development programs, and clinical trials for GPS Cancer.

Dr. Reddy joined NantHealth in December of 2016 as Senior Executive Director of Medical Affairs and prior to that, he served as CMO at Caris Life Sciences. Dr. Reddy has produced over 100 abstracts at major medical conferences and over 30 peer-reviewed publications since 2014. Dr. Reddy’s additional experience includes servicing as Chief of Staff at Los Alamitos Medical Center and actively practicing clinical hematology and oncology. Simultaneously, he held an adjunct faculty position at the Geffen/UCLA School of Medicine as a clinical instructor at Harbor-UCLA Medical Center. He is a member of the Los Angeles Biomedical Institute, American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC) and current SWOG investigator. His medical training includes fellowship training in hematology and medical oncology and therapeutics research at the City of Hope in Duarte, CA and Internal Medicine residency at Harbor-UCLA Medical Center. Dr. Reddy received his MD from the Geffen/UCLA School of Medicine after receiving his BS in biomedical sciences at the University of California, Riverside.

NantHealth  founder and CEO, Dr. Patrick Soon-Shiong said that appointing Dr. Reddy and his experience to our leadership team will be highly valuable to the evolution of the GPS Cancer initiative.  With extensive background in hematology, medical oncology and therapeutics research, Dr. Reddy will play a key role in helping NantHealth achieve victory in the war against cancer.